Suppliers / PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma

PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma

United States Updated 9 July 2026

PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma is a finished-dose manufacturer based in United States. It appears in 41 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 1 August 2025 as NAI.

0
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
41
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 1 August 2025 NAI US FDA
  • 28 January 2025 NAI US FDA
  • 15 September 2021 NAI US FDA
  • 6 February 2020 NAI US FDA
  • 22 February 2019 VAI US FDA
  • 15 May 2018 NAI US FDA
  • 12 January 2018 NAI US FDA
  • 8 July 2016 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Greenville, United States 1017687

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA 41 1

Comparing suppliers?

Choose your molecules and target markets. PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was NAI, on 1 August 2025.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates